Tower Research Capital (TRC)’s CORINDUS VASCULAR ROBOTICS, INC CVRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-1,439
| Closed | -$6K | – | 4878 |
|
|
2019
Q3 | $6K | Sell |
1,439
-22,227
| -94% | -$80.6K | ﹤0.01% | 3278 |
|
|
2019
Q2 | $70K | Sell |
23,666
-21,784
| -48% | -$54.6K | ﹤0.01% | 1393 |
|
|
2019
Q1 | $79K | Buy |
45,450
+26,398
| +139% | +$36.5K | ﹤0.01% | 1546 |
|
|
2018
Q4 | $16K | Sell |
19,052
-1,310
| -6% | -$1.56K | ﹤0.01% | 2144 |
|
|
2018
Q3 | $29K | Buy |
+20,362
| New | +$22.3K | ﹤0.01% | 2112 |
|
|
2018
Q2 | – | Sell |
-19,889
| Closed | -$27K | – | 4330 |
|
|
2018
Q1 | $27K | Sell |
19,889
-2,093
| -10% | -$2.43K | ﹤0.01% | 2029 |
|
|
2017
Q4 | $22K | Buy |
21,982
+10,433
| +90% | +$11.8K | ﹤0.01% | 2004 |
|
|
2017
Q3 | $18K | Buy |
11,549
+11,159
| +2,861% | +$18.7K | ﹤0.01% | 2808 |
|
|
2017
Q2 | $1K | Buy |
+390
| New | +$520 | ﹤0.01% | 2579 |
|
|
2016
Q2 | – | Sell |
-3,340
| Closed | -$3K | – | 5292 |
|
|
2016
Q1 | $3K | Buy |
+3,340
| New | +$5.74K | ﹤0.01% | 3227 |
|
|
2015
Q4 | – | Sell |
-2,351
| Closed | -$7K | – | 5367 |
|
|
2015
Q3 | $7K | Sell |
2,351
-5,056
| -68% | -$18.3K | ﹤0.01% | 2601 |
|
|
2015
Q2 | $26K | Buy |
+7,407
| New | +$31.6K | ﹤0.01% | 1888 |
|
Tower Research Capital (TRC)'s CVRS Position: Q4 2019 in Review
Tower Research Capital (TRC) sold out of CORINDUS VASCULAR ROBOTICS, INC (CVRS) in Q4 2019, closing a stake of 1,439 shares — an estimated $6K sold.
Tower Research Capital (TRC) first reported a position in CVRS in Q2 2015 and held it in 12 quarters. The position peaked at $79K in Q1 2019. 0 funds tracked by Wall St. Rank hold CVRS as of Q4 2019.
- Tower Research Capital (TRC) reported no remaining CORINDUS VASCULAR ROBOTICS, INC position as of Q4 2019 after selling out during the quarter.
- Tower Research Capital (TRC) sold 1,439 CORINDUS VASCULAR ROBOTICS, INC shares in Q4 2019, an estimated $6K.
- Tower Research Capital (TRC) first reported a position in CORINDUS VASCULAR ROBOTICS, INC in Q2 2015 and held it in 12 quarters.
- Tower Research Capital (TRC)'s CORINDUS VASCULAR ROBOTICS, INC position peaked at $79K in Q1 2019.
- 0 funds tracked by Wall St. Rank held CORINDUS VASCULAR ROBOTICS, INC as of Q4 2019.
Based on Tower Research Capital (TRC)'s 13F filing for Q4 2019, filed 7 Feb 2020.